Tumor invasion as dysregulated cell motility.

Abstract:

:Investigations across a range of disciplines over the past decade have brought the study of cell motility and its role in invasion to an exciting threshold. The biophysical forces proximally involved in generating cell locomotion, as well as the underlying signaling and genomic regulatory processes, are gradually becoming elucidated. We now appreciate the intricacies of the many cellular and extracellular events that modulate cell migration. This has enabled the demonstration of a causal role of cell motility in tumor progression, with various points of 'dysregulation' of motility being responsible for promoting invasion. In this paper, we describe key fundamental principles governing cell motility and branch out to describe the essence of the data that describe these principles. It has become evident that many proposed models may indeed be converging into a tightly-woven tapestry of coordinated events which employ various growth factors and their receptors, adhesion receptors (integrins), downstream molecules, cytoskeletal components, and altered genomic regulation to accomplish cell motility. Tumor invasion occurs in response to dysregulation of many of these modulatory points; specific examples include increased signaling from the EGF receptor and through PLC gamma, altered localization and expression of integrins, changes in actin modifying proteins and increased transcription from specific promoter sites. This diversity of alterations all leading to tumor invasion point to the difficulty of correcting causal events leading to tumor invasion and rather suggest that the underlying common processes required for motility be targeted for therapeutic intervention.

journal_name

Semin Cancer Biol

authors

Kassis J,Lauffenburger DA,Turner T,Wells A

doi

10.1006/scbi.2000.0362

keywords:

subject

Has Abstract

pub_date

2001-04-01 00:00:00

pages

105-17

issue

2

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(00)90362-6

journal_volume

11

pub_type

杂志文章,评审
  • Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.

    abstract::As stated by Otto Warburg nearly a century ago, cancer is a metabolic disease, a fermentation caused by malfunctioning mitochondria, resulting in increased anabolism and decreased catabolism. Treatment should, therefore, aim at restoring the energy yield. To decrease anabolism, glucose uptake should be reduced (ketoge...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.01.005

    authors: Schwartz L,Seyfried T,Alfarouk KO,Da Veiga Moreira J,Fais S

    更新日期:2017-04-01 00:00:00

  • ER stress and hexosamine pathway during tumourigenesis: A pas de deux?

    abstract::Both the hexosamine biosynthetic pathway (HBP) and the endoplasmic reticulum (ER) are considered sensors for the nutritional state of the cell. The former is a branch of the glucose metabolic pathway that provides donor molecules for glycosylation processes, whereas the second requires co-translational N-glycosylation...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2015.04.001

    authors: Vasseur S,Manié SN

    更新日期:2015-08-01 00:00:00

  • Mitogen-activated protein kinases in hepatocellular carcinoma development.

    abstract::Hepatocellular carcinoma (HCC) is among the most frequently occurring cancers and the leading causes of cancer mortality worldwide. Identification of the signaling pathways regulating liver carcinogenesis is critical in developing novel chemoprevention and targeted therapies. Mitogen-activated protein kinases (MAPKs),...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.10.011

    authors: Min L,He B,Hui L

    更新日期:2011-02-01 00:00:00

  • Clinical significance of the Thomsen-Friedenreich antigen.

    abstract::What is the clinical significance of the expression by common human carcinomas of the Thomsen-Friedenreich (TF) antigen? Described as a terminal disaccharide which is a precursor of MN blood group antigens, it was discovered as a laboratory curiosity 60 years ago, yet its cancer-association has only been appreciated i...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: MacLean GD,Longenecker BM

    更新日期:1991-12-01 00:00:00

  • Proteoglycan signaling in tumor angiogenesis and endothelial cell autophagy.

    abstract::The need for more effective cancer therapies is omnipresent as the ever-complex, and highly adaptive, mechanisms of tumor biology allow this disease to elude even the most stringent treatment options. The expanding field of proteoglycan signaling is enticing as a reservoir of potential drug targets and prospects for n...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.05.003

    authors: Gubbiotti MA,Buraschi S,Kapoor A,Iozzo RV

    更新日期:2020-05-01 00:00:00

  • Current and upcoming mitochondrial targets for cancer therapy.

    abstract::Mitochondria are essential intracellular organelles that regulate energy metabolism, cell death, and signaling pathways that are important for cell proliferation and differentiation. Therefore, mitochondria are fundamentally implicated in cancer biology, including initiation, growth, metastasis, relapse, and acquired ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.06.006

    authors: Kim HK,Noh YH,Nilius B,Ko KS,Rhee BD,Kim N,Han J

    更新日期:2017-12-01 00:00:00

  • Human papillomaviruses and skin cancer.

    abstract::Human papillomavirus (HPV)-induced skin warts are classically benign lesions. However an association between specific HPV types and skin cancer becomes obvious in epidermodysplasia verruciformis (EV). The analysis of this disease suggests that lesions infected with HPV types 5 and 8 carry a high risk of developing squ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Pfister H

    更新日期:1992-10-01 00:00:00

  • Tumour escape from immune surveillance through dendritic cell inactivation.

    abstract::Dendritic cells (DC) are central to the initiation of immunity. To induce immune reactivity, DC are recruited at the site of antigen expression, uptake antigens and migrate to secondary lymphoid organs while receiving activation signals delivered by pathogens, dying cells, and/or T cells. Tumours can escape the immune...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2001.0400

    authors: Vicari AP,Caux C,Trinchieri G

    更新日期:2002-02-01 00:00:00

  • Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.

    abstract::Cancer, being the most prevalent and resistant disease afflicting any gender, age or social status, is the ultimate challenge for the scientific community. The new generation therapeutics for cancer management has shifted the approach to personalized/precision medicine, making use of patient- and tumor-specific marker...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.023

    authors: Zafar S,Beg S,Panda SK,Rahman M,Alharbi KS,Jain GK,Ahmad FJ

    更新日期:2019-08-20 00:00:00

  • Current and future systemic treatments for renal cell carcinoma.

    abstract::Systemic treatment of renal cell carcinoma has changed dramatically since 2007, with the development and approval of six new agents, which target complex molecular pathways regulating tumour angiogenesis and cell proliferation and survival. These treatments have significantly improved survival times in metastatic rena...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.06.004

    authors: Fisher R,Gore M,Larkin J

    更新日期:2013-02-01 00:00:00

  • NF-κB deregulation in splenic marginal zone lymphoma.

    abstract::Splenic marginal zone lymphoma is a rare mature B-cell malignancy involving the spleen, bone marrow and blood. Over the past years, the rapid expansion of sequencing technologies allowing the genome-wide assessment of genomic, epigenetic and transcriptional changes has revolutionized our understanding of the biologica...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2016.08.002

    authors: Spina V,Rossi D

    更新日期:2016-08-01 00:00:00

  • Bacterial infection increases risk of carcinogenesis by targeting mitochondria.

    abstract::As up to a fifth of all cancers worldwide, have now been linked to microbial infections, it is essential to understand the carcinogenic nature of the bacterial/host interaction. This paper reviews the bacterial targeting of mediators of mitochondrial genomic fidelity and of mitochondrial apoptotic pathways, and compar...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.07.003

    authors: Strickertsson JAB,Desler C,Rasmussen LJ

    更新日期:2017-12-01 00:00:00

  • Role of cell surface proteoglycans in cancer immunotherapy.

    abstract::Over the past few decades, understanding how tumor cells evade the immune system and their communication with their tumor microenvironment, has been the subject of intense investigation, with the aim of developing new cancer immunotherapies. The current therapies against cancer such as monoclonal antibodies against ch...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.07.012

    authors: Espinoza-Sánchez NA,Götte M

    更新日期:2020-05-01 00:00:00

  • Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.

    abstract::Colorectal cancer (CRC) is one of the leading causes of cancer related-deaths. The risk of development of CRC is complex and multifactorial, and includes disruption of homeostasis of the intestinal epithelial layer mediated though dysregulations of tumor suppressing/promoting signaling pathways. Guanylate cyclase 2C (...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.08.011

    authors: Yarla NS,Gali H,Pathuri G,Smriti S,Farooqui M,Panneerselvam J,Kumar G,Madka V,Rao CV

    更新日期:2019-06-01 00:00:00

  • Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton.

    abstract::A key regulator of cell morphology is the actin cytoskeleton and it has long been appreciated that the cytoskeleton is characteristically altered in cancer. Actin is organized into polymeric structures with distinct dynamics which in turn participate in a wide variety of cell processes including adhesion, migration, c...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.08.004

    authors: O'Neill GM,Stehn J,Gunning PW

    更新日期:2008-02-01 00:00:00

  • The JAK/STAT3 axis: A comprehensive drug target for solid malignancies.

    abstract::Intercellular communication between tumor cells, immune cells and the stroma characterises the tumor microenvironment, which is instrumental for establishing the ecological niche that fosters tumor growth and metastasis. While tumor cell intrinsic STAT3 signaling provides a crucial axis to support cell proliferation a...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.06.001

    authors: Huynh J,Etemadi N,Hollande F,Ernst M,Buchert M

    更新日期:2017-08-01 00:00:00

  • Definition of tumor antigens suitable for vaccine construction.

    abstract::The treatment of cancer with tumor vaccines has been a goal of physicians and scientists ever since effective immunization against infectious disease with vaccines was developed. In the past, major tumor antigens had not been molecularly characterized. Recent advances are, however, beginning to define potential molecu...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/1044-579x(95)90001-2

    authors: Lewis JJ,Houghton AN

    更新日期:1995-12-01 00:00:00

  • Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions.

    abstract::Higher grade histological transformation of follicular lymphoma (FL) to more aggressive diffuse large B-cell lymphomas (DLBCL) occurs in 10-60% of the cases. Review of the current knowledge of genetic and molecular alterations associated with the higher grade transformation of FCL suggests that the process that leads ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/s1044-579x(03)00015-4

    authors: Lossos IS,Levy R

    更新日期:2003-06-01 00:00:00

  • The molecular basis of targeting protein kinases in cancer therapeutics.

    abstract::In this paper, we provide an overview of targeted anticancer therapies with small molecule kinase inhibitors. First, we discuss why a single constitutively active kinase emanating from a variety of aberrant genetic alterations is capable of transforming a normal cell, leading it to acquire the hallmarks of a cancer ce...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.04.001

    authors: Tsai CJ,Nussinov R

    更新日期:2013-08-01 00:00:00

  • Fibronectin and cancer: rationales for the use of antiadhesives in cancer treatment.

    abstract::Alterations in the rate and pattern of cell movement are prominent features of many human diseases, including inflammation, cardiovascular disease and cancer. The ability to regulate the interactions of cells with each other and with adhesion factors in extracellular matrices therefore offers a novel approach to the t...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Humphries MJ

    更新日期:1993-10-01 00:00:00

  • Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics.

    abstract::The dysregulation of apoptosis is a key step in developing cancers, and mediates resistance to cancer therapy. Commitment to apoptosis is caused by permeabilization of the outer mitochondrial membrane, a process regulated by the interactions between different proteins of Bcl-2 family. Furthermore, Bcl-2 family protein...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2013.08.008

    authors: Yu L,Liu S

    更新日期:2013-12-01 00:00:00

  • Targeting p53 for the treatment of cancer.

    abstract::Dysfunction of the TP53 (p53) gene occurs in most if not all human malignancies. Two principal mechanisms are responsible for this dysfunction; mutation and downregulation of wild-type p53 mediated by MDM2/MDM4. Because of its almost universal inactivation in malignancy, p53 is a highly attractive target for the devel...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.07.005

    authors: Duffy MJ,Synnott NC,O'Grady S,Crown J

    更新日期:2020-07-31 00:00:00

  • Repurposing drugs in oncology: From candidate selection to clinical adoption.

    abstract::Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of existing medicines developed in other disease areas. Such a strategy includes the identification of candidate drugs, clinical development, drug licensing, reimbursement and clinical implementation. This review outlines a l...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.01.008

    authors: Pantziarka P,Verbaanderd C,Huys I,Bouche G,Meheus L

    更新日期:2020-01-23 00:00:00

  • Mammary tumorigenesis and metastasis in transgenic mice.

    abstract::The transgenic mouse has emerged as an important model system to assess the transforming potential of oncogenes in the mammary epithelium. Mammary gland-specific expression of oncogenes in transgenic mice has resulted in the induction of a variety of phenotypes ranging from benign epithelial hyperplasias to metastatic...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Webster MA,Muller WJ

    更新日期:1994-02-01 00:00:00

  • Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment.

    abstract::Epigenetic alterations of the genome such as DNA promoter methylation and chromatin remodeling play an important role in tumorigenesis. Recent findings indicate epigenetic modifications as key factors in breast carcinogenesis. These modifications are quite appealing as targets for preventative care and therapeutics be...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2009.02.007

    authors: Dworkin AM,Huang TH,Toland AE

    更新日期:2009-06-01 00:00:00

  • A molecular genetic model of human bladder carcinogenesis.

    abstract::Human bladder carcinogenesis stands as a paradigm for research on the molecular genetic mechanisms of chemical carcinogenesis. The pathogenesis of bladder cancer is multistage with a typical onset later in life. Epidemiological studies associate occupational exposure to aromatic amines with increased bladder cancer ri...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Reznikoff CA,Kao C,Messing EM,Newton M,Swaminathan S

    更新日期:1993-06-01 00:00:00

  • Antisense oligonucleotides.

    abstract::Growing evidence indicates that antisense oligodeoxynucleotides can specifically inhibit gene expression thereby providing an essential tool for understanding gene function and the potential to affect abnormal cell proliferation. Because oncogene activation is intimately involved in tumour initiation and progression, ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:

    authors: Calabretta B,Skorski T,Zon G

    更新日期:1992-12-01 00:00:00

  • NanoString in the screening of genetic abnormalities associated with thyroid cancer.

    abstract::In the setting of cancer pathology, molecular characterization of tumors providing diagnostic and predictive information is acquiring more and more relevance. Moreover, the advent of innovative technologies continuously improves the knowledge of the molecular landscape of tumors and strengthens the links between clini...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.10.004

    authors: Macerola E,Poma AM,Basolo F

    更新日期:2020-10-19 00:00:00

  • Repurposing amino-bisphosphonates by liposome formulation for a new role in cancer treatment.

    abstract::Amino-bisphosphonates (N-BPs) have been commercially available for over four decades and are used for the treatment of osteoporosis, Paget's disease, hypercalcemia of malignancy, and bone metastases derived from various cancer types. Zoledronate and alendronate, two of the most potent N-BPs, have demonstrated direct t...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.12.001

    authors: La-Beck NM,Liu X,Shmeeda H,Shudde C,Gabizon AA

    更新日期:2019-12-23 00:00:00

  • Spatial genome organization in the formation of chromosomal translocations.

    abstract::Chromosomal translocations and genomic instability are universal hallmarks of tumor cells. While the molecular mechanisms leading to the formation of translocations are rapidly being elucidated, a cell biological understanding of how chromosomes undergo translocations in the context of the cell nucleus in vivo is larg...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.10.008

    authors: Meaburn KJ,Misteli T,Soutoglou E

    更新日期:2007-02-01 00:00:00